Related Experiment Video
Updated: May 23, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Next-generation ICDs: Individualised Selection for Improved Cardiac Outcomes
Lin-Thiri Toon1,2, Christopher Monkhouse3,4, Waqas Ullah1,2
1Department of Cardiology, University Hospital Southampton NHS Foundation Trust Southampton, UK.
Insights
Sudden cardiac death from ventricular tachyarrhythmias is a major concern. Implantable cardioverter-defibrillators (ICDs) are crucial for prevention, with ongoing innovations personalizing patient care.
Area of Science:
- Cardiology
- Biomedical Engineering
- Public Health
Background:
- Cardiovascular disease causes significant global mortality, with sudden cardiac death (SCD) often resulting from ventricular tachyarrhythmias.
- High incidence of out-of-hospital cardiac arrests in the UK and low survival rates highlight the need for effective interventions.
- Arrhythmia recurrence rates remain substantial, underscoring the importance of advanced preventative strategies.
Purpose of the Study:
- To review the evolution and current landscape of implantable cardioverter-defibrillators (ICDs) for managing cardiac arrhythmias.
- To discuss the individualized selection criteria for different ICD systems.
- To highlight emerging technologies in cardiac rhythm management.
Main Methods:
- Review of existing literature on ICDs, their technological advancements, and clinical applications.
- Analysis of current trends in device design, implantation techniques, and arrhythmia detection algorithms.
- Examination of patient-specific factors influencing device choice.
Main Results:
- Transvenous single-chamber ICDs are standard, with dual-chamber and CRT devices for specific patient needs.
- Subcutaneous and extravascular ICDs offer alternatives, mitigating lead-related complications.
- Personalized device selection is paramount, considering patient profiles and preferences.
Conclusions:
- ICDs have significantly advanced in preventing sudden cardiac death, with continuous innovation driving personalized strategies.
- The choice of ICD system requires careful consideration of individual patient characteristics and clinical context.
- Future advancements, including leadless pacing, promise further optimization of arrhythmia management.
Abstract:
Cardiovascular disease is a major global cause of death, with sudden cardiac death accounting for up to half of cases, largely due to ventricular tachyarrhythmias. In the UK, approximately 60,000 out-of-hospital cardiac arrests occur annually, with survival rates of only 2-12%. Younger individuals are also affected, with one cardiac-related death daily in those under 35 years of age. Despite advances in care, arrhythmia recurrence remains high (40-50% within 5 years). ICDs have become pivotal in preventing sudden cardiac death, with continuous innovations in device design, implantation, and arrhythmia detection since their introduction in 1980. Transvenous single-chamber ICDs remain the standard, while dual-chamber and CRT defibrillator devices serve patients needing atrial pacing or heart failure support. Subcutaneous and extravascular ICD systems protect patients not requiring pacing while avoiding lead-related risks. Device selection must be individualised, considering clinical profile, comorbidities, lifestyle, patient preferences, and operator expertise. Ongoing advances, including leadless pacing and modular anti-tachycardia pacing systems, continue to expand personalised device strategies.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Cardiac Catheterization I: Pre-Procedure Overview
Coronary Artery Disease V: Interprofessional Care

